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First, a preliminary study was conducted looking for the optimum sperm
concentration to be used for analysis with the Computer-Assisted Sperm Analysis
(CASA). Results showed that 75x106 sperm cells/mL is the optimum one. Then, the
actions of relaxin on sperm motility were evaluated by determining the effect of relaxin
on full motility characteristics of spermatozoa during storage, using CASA; then
identifying the relaxin receptors on spermatozoa, and finally establishing actions of
relaxin in intraspermatic cAMP content. Motile spermatozoa were selected through
percoll gradient and incubated for 1 hour with 4 relaxin concentrations at 37oC, during
four days. Relaxin affected sperm motility (P<0.05). This action appears associated with
the presence of relaxin receptors RXFP1 and RXFP2 that were found in spermatozoa.
However, the cAMP levels were not affected by relaxin (P<0.05). This study indicates a
beneficial action of relaxin on sperm motility; however, its mechanism of action requires
further research.

Key words: relaxin hormone, boar semen, sperm motility, CASA system, storage

DEDICATION
Quisiera dedicar ésta tesis y todo mi trabajo realizado acá en la Universidad del
Estado de Mississippi (MSU) (Starkville, Mississippi - Estados Unidos de América) a
mis Padres Blaca Elvia Muñoz Suárez y Óscar de Jesús Rodríguez Castañeda, mis
hermanas Maria Fernanda Rodríguez Muñoz y Estefanía Rodríguez Muñoz, mi abuela
Betsabé Suárez Berrío, y en general a toda mi familia por su immenso apoyo, estímulo y
oraciones en éste proceso lejos de casa. Gracias por hacer de mí quien soy, y por ser la
inspiración de cada día para luchar.

I would like to dedicate this thesis and all my work done here at MSU to my
Parents Blanca and my Dad Oscar, my sisters Mafe and Estefanía, my Granny Betsabé,
and in general to my whole family for their immense support, encouragement, and
prayers in this process away from home. Thanks for making me who I am, and for being
my inspiration of every day to strive.

ii

ACKNOWLEDGEMENTS
First, I want to thank Dr. Nélida Rodríguez Osorio and Dr. Delmis Omar
Camargo Rodríguez for being the first connection I ever had with MSU. I would like to
express my most sincere gratitude to all the people who guided me in one or another way
to accomplish this thesis. Special thanks to my major professor Dr. Peter L. Ryan for his
invaluable advisory during my academic formation; to him, for being more than my
advisor, professor or the interim of the Provost office at MSU, simply for being a human,
what makes him great. My gratitude goes to Jean Magloire Feugang, for all his enormous
support, guidance and professionalism; his knowledge exceeded all my expectations, and
for had made me realized about the truly meaning of research and sciences; and more
importantly, because of his friendship. I want to extend my appreciation to the members
of my committee Dr. Mark Crenshaw, Dr. Dean Jousan and Dr. David Christiansen for
their wise and opportune counseling. My special thanks also go to all the graduate
students, staff and faculty members at the Department of Animal and Dairy Sciences with
whom I have been spending and sharing more than two years of my life. I will miss our
Tuesday lunch tradition at Taste of China restaurant with some of the graduate students
and staff.
My most sincere and enormous gratefulness is for my Mom, Dad, sisters and my
Granny. Their love, support, encouragement are priceless.

iii

TABLE OF CONTENTS
Page
DEDICATION .................................................................................................................... ii
ACKNOWLEDGEMENTS ............................................................................................... iii
LIST OF TABLES ............................................................................................................. vi
LIST OF FIGURES .......................................................................................................... vii
LIST OF ABBREVIATIONS ............................................................................................ ix
CHAPTER
I.

INTRODUCTION .............................................................................................1
1.1

II.

Swine Industry .......................................................................................1

REVIEW OF PERTINENT LITERATURE .....................................................4
2.1
2.2

Spermatogenesis ....................................................................................4
Relaxin ...................................................................................................4
2.2.1 Effects of Relaxin on Sperm Motility ..............................................5
2.2.2 Relaxin receptors - Structure ...........................................................7
2.2.3 RXFP1 and RXFP2 ..........................................................................9
2.2.4 RXFP3 and RXFP4 ........................................................................11
2.3
Analysis of sperm motility: Use of the Computer Assisted
Sperm-Analysis (CASA) approach ......................................................12
2.3.1 General sperm motility parameters ................................................14
2.3.2 Velocities .......................................................................................14
2.3.3 Progression ratios ...........................................................................14
2.3.4 Head movements ............................................................................15
2.4
Relaxin hormone and the second messenger cyclic adenosine
3’,5’-monophosphate in sperm motility ...............................................16
III.

PRELIMINARY STUDY ................................................................................18
3.1
3.2

Abstract ................................................................................................18
Introduction ..........................................................................................18
iv

3.3

Materials and Methods.........................................................................18
3.3.1 Boar sperm cells preparation .........................................................20
3.3.2 Analysis of total boar spermatozoa cells and motility
parameters ......................................................................................20
3.3.3 Statistical Analysis .........................................................................20
3.4
Results ..................................................................................................21
3.5
Discussion ............................................................................................26
3.6
Conclusions ..........................................................................................26
IV.

EFFECTS OF RELAXIN HORMONE ON MOTILITY
CHARACTERISTICS OF BOAR SPERMATOZOA DURING
STORAGE .......................................................................................................30
4.1
4.2
4.3

Abstract ................................................................................................30
Introduction ..........................................................................................30
Materials and Methods.........................................................................30
4.3.1 Semen Samples ..............................................................................32
4.3.2 Semen Treatment ...........................................................................32
4.3.3 Analysis of Sperm Motility............................................................32
4.3.4 Immunofluorescence Detection of RXFP1 and RXFP2 on
Boar Spermatozoa ..........................................................................33
4.3.5 Measurement of cAMP Content in Boar Spermatozoa..................34
4.3.6 Statistical Analysis .........................................................................35
4.4
Results ..................................................................................................36
4.4.1 Sperm motility ...............................................................................36
4.4.2 Immunofluorescense detection of RXFP1 and RXFP2 .................43
4.4.3 Measurement of cAMP content in boar spermatozoa ....................44
4.5
Discussion ............................................................................................45
4.6
Conclusion ...........................................................................................52
V.

CONCLUSIONS..............................................................................................53

REFERENCES ..................................................................................................................55

v

LIST OF TABLES
TABLE

Page

2.1

Multiple GPCR signaling pathways with coupling of relaxin family
peptides. Re-drawn from Hsu et al. (2005) ........................................................11

4.1

Effect of increasing relaxin concentration on boar sperm motility during
storage. ...............................................................................................................37

4.2

Effect of an increasing relaxin concentration on the straight line velocity
(VSL) of boar spermatozoa during storage. .......................................................40

4.3

Effect of relaxin hormone (500 ng/mL) on full motility parameters of
boar sperm on day 5th of storage. .......................................................................43

vi

LIST OF FIGURES
FIGURE

Page

2.1

Different track speed and movement of spermatozoa measured by the
Hamilton-Thorn Motility Analyzer. Velocities (µm/s): Curvilinear
velocity (VCL); average path velocity (VAP); straight line velocity
(VSL). Progression ratios (%): linearity (LIN = VSL/VCL x 100);
straightness (STR = VSL/VAP x 100). Head movements (µm):
amplitude of lateral head displacement (ALH). Re-drawn from Liu et al.
(1991). ................................................................................................................15

3.1

Total number of sperm cells obtained by CASA when using three
different sperm concentrations (50, 75 and 100 x 106 boar sperm
cells/mL) during three consecutive days (1, 2, and 3) of storage. Data
are shown as mean values ± SEM. Significant differences (P < 0.05)
within the same day are indicated by different letters (a, b, c). ............................22

3.2

Motile spermatozoa obtained by CASA when using three different
sperm concentrations (50, 75 and 100 x 106 boar sperm cells/mL) during
three consecutive days (1, 2, and 3) of storage. Data are shown as mean
percentage (%) ± SEM from the total number of sperm cells. Significant
differences (P < 0.05) within the same day are indicated by different
letters (a, b, c). .......................................................................................................23

3.3

Progressive spermatozoa obtained by CASA when using three different
sperm concentrations (50, 75 and 100 x 106 boar sperm cells/mL) during
three consecutive days (1, 2, and 3) of storage. Data are shown as mean
percentage (%) ± SEM from the total number of sperm cells. There were
not significant differences (P < 0.05) within the same day between
sperm concentrations. .........................................................................................24

3.4

Straight line velocity (VSL, µm/s) of spermatozoa obtained by CASA
when using three different sperm concentrations (50, 75 and 100 x 106
boar sperm cells/mL) during three consecutive days (1, 2, and 3) of
storage. Data are shown as mean values ± SEM. Significant differences
(P < 0.05) within the same day are indicated by different letters (a, b, c) ............25

vii

3.5

Curvilinear velocity (VCL, µm/s) of spermatozoa obtained by CASA
when using three different sperm concentrations (50, 75 and 100 x 106
boar sperm cells) during three consecutive days (1, 2, and 3) of storage.
Data are shown as mean values ± SEM (P < 0.05). There were not
significant differences within the same day between sperm
concentrations.....................................................................................................26

4.1

Effect of porcine relaxin on proportion of progressive sperm. Data are
shown as mean percentage (%) ± SEM from the total number of sperm
cells. Significant differences (P < 0.05) within the same day are
indicated by different letters (a, b). ......................................................................38

4.2

Effects of relaxin on rapidly moving spermatozoa (≥ 45 µm/sec) during
storage. Data are shown as mean percentage (%) ± SEM from the total
number of sperm cells. Significant differences (P < 0.05) within the
same day are indicated by different letters (a, b). ................................................39

4.3

Effects of porcine relaxin on the straightness (STR, % = VSL/VAP x
100) of spermatozoa. Data are shown as mean (%) values ± SEM.
Significant differences (P < 0.05) within the same day are indicated by
different letters (a, b)............................................................................................41

4.4

Effects of porcine relaxin on the linearity (LIN, % = VSL/VCL x 100)
of spermatozoa. Data are shown as mean (%) values ± SEM. Significant
differences (P < 0.05) within the same day are indicated by different
letters (a, b). .........................................................................................................42

4.5

Determination of relaxin receptors RXFP1 (Panels C and D) and
RXFP2 (Panels E and F) on boar spermatozoa. Negative control (Panels
A and B). Pictures on top with FITC staining only (Panels A, C and E).
Pictures at the bottom with FITC and DAPI stainings (Panels B, D and
F). .......................................................................................................................44

4.6

Intraspermatic cAMP content in boar sperm cells after supplementation
with relaxin through storage. Data are shown as mean percentage (%) ±
SEM. There were not significant differences (P < 0.05) within the same
day of storage between relaxin treatments. ........................................................45

viii

LIST OF ABBREVIATIONS
A1 Differentiated A1 spermatogonia
A2 Differentiated A2 spermatogonia
A3 Differentiated A3 spermatogonia
A4 Differentiated A4 spermatogonia
Aal Undifferentiated A aligned spermatogonia
AI Artificial insemination
ALH Amplitude of lateral head displacement
ANOVA Analysis of variance
Apr Undifferentiated A paired spermatogonia
As Undifferentiated A single spermatogonia
ATP Adenosine 5’-triphosphate
B B spermatogonia
BCF Beat cross frequency
BTS Beltsville thawing solution
cAMP Cyclic adenosine 3’,5’-monophosphate
CASA Computer-Assisted Sperm Analysis
Casp Cysteine-rich regions
DAPI 4’, 6-diamidino-2-phenylindole
ESC Primary human endometrial stromal cells from the cycle
FITC Fluorescein isothiocyanate
ix

g gravity
GLM General linear model
GPCR G-protein-coupled receptor
GPCR 135 Somatostatin and angiotensin-like peptide receptor
GPCR 142 G-protein-coupled receptor 142
GPR 100 G-protein-coupled receptor 142
Gαi G-proteins inhibiting α subunits
Gαs G-proteins stimulating α subunits
HCl Hydrochloric acid
HEK Human embryonic kidney 293T
IGF-I Insulin-like growth factor I
IGF-II Insulin-like growth factor II
IgG Immunoglobulin G
In Intermediate spermatogonia
INSL 3 Leydig cell insulin-like peptide or relaxin-like factor
INSL 4 Novel insulin-like peptide 4
INSL 5 Novel insulin-like peptide 5
INSL 6 Novel insulin-like peptide 6
INSL 7 Relaxin-3
IUPHAR International Union of Pharmacology LVII
LDLa Low density lipoprotein class A
LGRs Leucine-rich repeat-containing guanine nucleotide-binding (G-protein)-coupled
receptors
LGR 7 Leucine-rich repeat-containing G-protein-coupled receptor 7
x

LGR 8 Leucine-rich repeat-containing G-protein-coupled receptor 8
LIN Linearity
LSD Least significant difference
min Minutes
PBS Phosphate buffered saline solution
PKA Protein Kinase A
PVP Polyvinylpyrrolidone
R3 Relaxin-3
RLF Relaxin-like factor
rpm revolutions per minute
RXFP 1 Relaxin family peptide receptor 1
RXFP 2 Relaxin family peptide receptor 2
RXFP 3 Relaxin family peptide receptor 3
RXFP 4 Relaxin family peptide receptor 4
SALPR Somatostatin and angiotensin-like peptide receptor
SAS Statistical analysis system
SEM Standard error of the mean
STR Straightness
THP-1 Human monocyte cell line
VAP Average path velocity
VCL Curvilinear velocity
VSL Straight line velocity

xi

CHAPTER I
INTRODUCTION
1.1

Swine Industry
Pork has accompanied civilizations for several generations and it has become an

important source of protein and food for humans. According to the Food and Agriculture
Organization of the United Nations (FAO, 2002), the amount of pork consumed annually
worldwide to that date was 94 million metric tons, corresponding to 40% of the total red
meat consumed. The consumption of pork has increased parallel to the increasing world
population and swine numbers have risen too. Ten years back from 2002, the
consumption of pork has increased from 73 to 94 million metric tons (FAO, 2002). In the
same way, estimations have projected that the demand of pork will increased to 125
million metric tons by 2020. Surprisingly, most of this increase is estimated for countries
in development (Delgado et al., 1999). In the same way, there has been an increasing
interest in swine to be used as research models in biomedicine.
Research and swine producer management has become important in increasing
the numbers of swine worldwide. In fact, during the last decades, efficiency of production
and carcass composition has been improved by nutrition and genetic selection,
respectively. Similarly, there have been some other biotechnological techniques
employed such as artificial insemination (AI) that have constituted a major impact in the
industry. Likewise, the development of semen extenders has improved the success of AI,
allowing the possibility to use fresh semen for more than 5 days post-collection, further
1

optimizing the utilization of semen. In order to have a sustainable supply of pigs for
human consumption and research the swine industry must continue to improve their
standards at a reproductive level to meet these expectations. The development of a longterm boar semen storage system that would allow the transport of semen around the
world would be of great importance for the commercial swine industry.
The use of AI has facilitated and maximized the transfer of the best genetic
material over the last several decades. Conversely, when using frozen-thawed boar semen
(long-term semen storage) this goal has not been achieved completely. In addition, AI
also abolishes physical contact between animals, thus reducing the incidence of sexually
transmitted diseases. The utilization of frozen-thawed (cryopreserved) boar semen in the
swine industry for reproduction is low compared to other species. Reasons for that are the
reduced conception rates, smaller litter size and reduced farrowing rate (Jonhson et. al.,
1981) after AI with frozen-thawed boar semen compared to inseminations with fresh
semen (Almlid et al., 1987), despite the use of a higher number of spermatozoa (Pursel
and Johnson, 1975). Among the factors responsible for such reduced conception rates
when using frozen semen are: cooling of semen, methodology employed (Cochran et al.,
1984), composition of cryoprotectants (Wilmut and Polge, 1977), sperm concentration
and thawing temperature (Pace et al, 1981). It has been proposed that cryopreservation of
semen destroys the boar sperm head plasma membrane, promoting molecular and
biochemical changes that will later on affect the fertilization process (Buhr et al., 1989,
1994; Bailey et al., 2000). There is still a crucial need to maximize the use of
spermatozoa derived from high genetic merit boars. Therefore, the swine industry
routinely employs freshly diluted-semen whose short lifespan significantly reduces its
long-term application, despite the use of semen extenders. Consequently, the
2

identification and characterization of specific factors present in the seminal plasma of
swine semen, such as relaxin are of great importance (Kohsaka et al., 2001).
Relaxin is a small polypeptide (~6 Kda) discovered almost a century ago and is
well known as a hormone of pregnancy in many mammals (Hisaw, 1926; Sherwood,
2004). However, relaxin is detected in various reproductive and non-reproductive tissues
of both females and males. Relaxin family consists of several members having
pleiotropic roles in a variety of tissues and cells, including spermatozoa (Sherwood,
2004). Numerous in vivo (Sasaki et al., 2001) and in vitro (Juang et al., 1989) studies
have highlighted the beneficial role of relaxin on motility of boar spermatozoa.
Nonetheless, it is not known whether relaxin can extend the lifetime of spermatozoa
motility during storage, while maintaining acceptable fertility rates.
A preliminary study was conducted to determine the optimal boar sperm
concentration that would provide an adequate number of spermatozoa/sample (between
200 to 400 cells) to be analyzed by CASA. Consequently, results from this preliminary
study were employed in the study involving the evaluation of porcine relaxin hormone on
full motility characteristics of boar spermatozoa using CASA. Second, to assess relaxin
mode of action, a study was conducted to establish if relaxin receptors (RXFP1 and
RXFP2) were present on boar sperm membrane employing an immunofluorescent assay.
A final study measured the intracellular cAMP content in boar spermatozoa that have
been treated with relaxin and stored for up to 5 days at room temperature (18-21°C).

3

CHAPTER II
REVIEW OF PERTINENT LITERATURE
2.1

Spermatogenesis
The process of producing male gametes (spermatozoa) is called spermatogenesis.

The main goal of it is to supply males with a continuous source of gametes based on a
stem cell renovation (up to several years). Spermatogenesis is a complex and highly
coordinated process that takes place within the seminiferous tubules, and is comprised by
the combination of several cellular transformations in producing germ cells in the
seminiferous epithelium. In pigs as in mammals, this process is divided into three main
phases. The first one denominated as mitotic (spermatogonial or proliferative) phase; the
second one as the meiotic one, and the third one as the differentiation (spermiogenic)
phase (Russell et al., 1993). In pigs, during the first phase (proliferative phase), several
mitotic divisions take place, that at the end will generate a bigger number of B
spermatogonia. Four types of undifferentiated A spermatogonia are present [A single
(As), A paired (Apr), A aligned (Aal)], four types of differentiated A spermatogonia (A1,
A2, A3, and A4), intermidiate (In) and finally B spermatogonia; at this point
spermatogonia are diploid cells (Frankenhuis et al., 1982). The second phase (meiotic)
consists of a couple of meiotic divisions that gives rise to primary and secondary
spermatocytes. As soon as B spermatogonia (from the first phase) reach the stage of
primary spermatocytes they will have to move from interphase (immediately after they
divide) to enter the first meiotic prophase which is composed of five stages: preleptotene,
4

leptotene, zygotene, pachitene and diplotene. Progression of DNA synthesis and
replication is guaranteed by all the prophase stages. Later on, at the end of the second
meiotic division, haploid spermatids have been generated (Senger, 2003). Knowing that
the goal of a spermatozoon is to deliver the genetic material of males to an oocyte during
the process of fertilization, the third phase is in charge of making sperm cells that are
capable of achieve their main objective. During this phase, spermatids undergo a series of
changes, including the formation of the acrosome, condensation of the nucleus and
acquisition of motility. In making a spermatozoon motile, it is necessary to form a
flagellum and an energy supply that is achieved by the mitochondrial helix. During the
reshaping of sperm cells there is a significant decrease in cell size as well, that ultimately
gives rise to a sophisticated, self-propelled spermatozoon carrying a package of DNA and
enzyme (Eddy and O’Brien, 1994). All the changes observed during this third phase are
known as germ cell differentiation. Mature spermatozoa are released into the lumen of
seminiferous tubules, where spermatozoa start their transit through the different genital
tract structures until ejaculation occurs. Throughout this transit, sperm cells are exposed
to different seminal plasma molecules having specific effects on the motility of
spermatozoa. Relaxin is one of these molecules that have been found to affect sperm
motility; however, relaxin actions on sperm motility are not fully characterized.
2.2

Relaxin
Relaxin is a small polypeptide hormone (~6 Kda) that belongs to the structurally

related insulin-like hormones superfamily, which includes, insulin, insulin-like growth
factor-I (IGF-I), IGF-II, the Leydig cell insulin-like peptide (INSL3), which is also
referred to as relaxin-like factor (RLF), novel insulin-like peptides (INSL4, INSL5,
5

INSL6), and relaxin-3 (R3)/INSL7 (Bell et al., 1980, 1984; Rinderknecht and Humbel
1978; Hudson et al., 1983, 1984; Adham et al., 1993; Koman et al., 1996; Conklin et al.,
1999; Lok et al., 2000; Bathgate et al., 2002). The total sequence similarity between
relaxin and insulin is only about 25%, whereas the structural conformation of relaxin is
identical to that of insulin (Bathgate et al., 2006). The hormone was first identified by
Hisaw in 1926, when he realized that injecting virgin guinea pigs shortly after estrous
with serum from pregnant guinea pigs or rabbits promoted a relaxation of the pubic
ligament similar to that naturally occurring in pregnancy (Hisaw, 1926); however, the
hormone structure was not established until the 1970s (Schwabe and Harmon, 1978). The
source of relaxin is variable among species, and it is produced in the reproductive tract of
several mammals during pregnancy. While circulating relaxin is produced in the uterus of
guinea pigs and in the placenta of hamsters and rabbits. In pigs, mice and rats it is
produced in the corpus luteum (Sherwood, 1994).
Relaxin was initially named as a hormone of pregnancy in many mammals, due to
its pleiotropic actions on reproductive tissues during pregnancy such as inhibition of
uterine contractility, relaxation of the pelvic ligaments, development and growth of the
mammary gland, softening and enlargement of the cervix, vasodilation of the circulatory
vessels, and regulation of cardiovascular function (Sherwood, 1994). However, it has
been shown that the actions of relaxin go beyond its effects on the reproductive system.
Relaxin exerts several other functions in non-reproductive tissues such as kidney, lungs
and heart (Siebold, 1997). For instance, relaxin and its receptors are involved in allergic
responses (Bani et al., 1997), protection of the cardiovascular system, wound healing and
fibrosis (Halls et al., 2007; Sherwood, 2004) among others. Interestingly, relaxin is also
present in males. Loumaye et al. (1980) identified a relaxin-like substance in seminal
6

plasma of humans; Steinetz et al. (1959) recognized its bioactivity in the testes of
roosters, while Dubois and Dacheux, (1978) described relaxin in testes of boars. Kohsaka
et al. (2003) measured the content of immunoreactive relaxin in seminal plasma in both
bulls and boars; it was found to be 41.92 ng /mL and 2.35 ng /mL, respectively.
According to Kohsaka et al. (1992) and Lessing et al. (1986), the male accessory glands
appeared to be the source of relaxin, which is then secreted into the seminal plasma
(Kohsaka et al., 1988; Lessing et al., 1986; Juang et al., 1990; Sasaki et al., 2001), and
finally joining sperm cells after ejaculation (Kohsaka et al., 2001; Sasaki et al., 2001).
Nonetheless, some researchers have reported the prostate gland as the source of relaxin
(Yki-jarvinen et al., 1983; Hansell et al., 1991). Some research supports this hypothesis,
knowing that relaxin has been found in semen of men after surgical vasectomy, which
eliminates testicular and epididymal components from the ejaculate. In the same way, the
peptide hormone was found in the ejaculate of a pair of men with congenital absence of
the seminal vesicles and the vas deferens (so the ejaculate contains only components
from the prostate gland and distal structures). It was found that the content of relaxin was
still higher than in most samples from normal patients (Loumaye et al., 1980; Essig et al.,
1982b). De Cooman et al. (1983) also found that the first part of a human split ejaculate
possesses higher amounts of relaxin, confirming the previous findings, and giving
support to the idea of an extra-testes source of relaxin.
2.2.1

Effects of Relaxin on Sperm Motility
Several in vivo (Sasaki et al., 2001) and in vitro (Juang et al., 1989) studies have

reported the beneficial action of relaxin on boar sperm motility. Similar effects of relaxin
have been noticed in human sperm (Colon et al., 1986; Lessing et al., 1986). Even more,
7

other researchers have reported that the action of relaxin is not just limited to the
enhancement of sperm motility, but also promoted acrosome reaction in cryopreserved
and fresh swine spermatozoa (Miah et al., 2006). On the other hand, boar sperm motility
is inhibited by incubation with antirelaxin antiserum (Juang et al., 1987). The same
author also demonstrated that relaxin can preserve porcine sperm motility. According to
Juang et al. (1990) and Sasaki et al. (2001), immunoreactive relaxin in boar seminal
plasma positively correlates with sperm motility, although in human semen samples such
correlations were not found (Schieferstein et al., 1989; Brenner et al., 1987), suggesting
that the biological action of immunoreactive relaxin in humans may be different.
Conversely, in an in vitro study, the addition of anti-porcine relaxin antiserum, but not
normal rabbit serum, promotes a rapid decrease in the motility of washed human sperm,
but this effect is eliminated by preincubating the antiserum with excess of relaxin (Sarosi
et al., 1983). Lessing et al. (1986) evaluated effects of relaxin when added to whole
semen and washed spermatozoa from normal samples, normal samples aged for 5 h, and
initial low motility samples and evaluated the percentage of motility and forward
progressively motile sperm. Relaxin was observed to have no effect on the motility of
whole unwashed normal semen. The sperm-washing practice decreased motility of
normal samples, but supplementation with the porcine relaxin (10 to 100 ng/mL)
increased motility. Aging whole semen samples for 5 h at 37º C decreased motility, but
adding relaxin at a physiological range improved motility. When the washing procedure
was applied to aged spermatozoa motility was further reduced; however, relaxin did not
have a significant effect. When relaxin was added in the physiological range to samples
of initial low motility there was a positive improvement. Nevertheless, the washing
practice further reduced the motility of sample with initial low motility, but relaxin did
8

not have any effect, suggesting that there is a certain damage level of sperm in terms of
motility from which recovery is no longer possible. Knowing that aging or storage reduce
motility of normal sperm, it led Lessing et al. (1986) to hypothesize that immunoreactive
relaxin in seminal plasma loses biological action with storage. To prove this previous
hypothesis, normal sperm samples were washed, stored for 5 h at 37º C and finally
treated with their original seminal plasma, original seminal plasma with added relaxin, or
fresh seminal plasma alone. As a result, the fresh seminal plasma or the original seminal
plasma plus added relaxin significantly increased sperm motility, while the original
seminal plasma did not show any significant effect, therefore supporting the hypothesis.
Some other studies have reported the beneficial effect of relaxin on aged (5 h at 37º C)
human sperm (Colon et al., 1986). In the same way, Park et al. (1988) also confirmed
such effects on aged human sperm using porcine relaxin. Chan and Tang (1984) used
washed normal human sperm stored with relaxin and did not find any effect on sperm
motility. In contrast to these previous findings, relaxin in boar seminal plasma has a
positive correlation with motility of sperm (Juang et al., 1989).
Thus, it has been proposed that the physiological actions of relaxin on fertility and
sperm motility are driven by specific cell-surface receptors for relaxin on spermatozoa
(Kohsaka et. al., 2001)
2.2.2

Relaxin receptors - Structure
Although relaxin hormone was discovered almost 85 years ago, the identification

of its receptors was not until the beginning of this decade (Bathgate et al., 2006). Four
receptors have been identified that are the physiological targets for the relaxin family
peptides: LGR7, LGR8, GPCR135 (SALPR or somatostatin and angiotensin-like peptide
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receptor) and GPCR142 (GPR100). All four receptors are class I (rhodopsin like) Gprotein-coupled relaxin family peptide receptors (GPCRs). Recently, the International
Union of Pharmacology LVII (IUPHAR) has renamed the relaxin family receptors as
follows: LGR7 as RXFP1; LGR8 as RXFP2, GPCR135 as RXFP3; and GPCR142 as
RXFP4 (Bathgate et al., 2006).
2.2.3

RXFP1 and RXFP2
Due to the advances in genome sequencing, the identification of novel genes has

been possible through their sequence similarities with respect to known genes in the
hormonal signaling pathway (Hsu et al., 2000). The determination of LGRs (leucine-rich
repeat-containing G-protein-coupled receptors), a group of GPCRs was due to the
research developed in paralogs of the known gonadotropin and thyrotropin. Research
carried out in different species on LGRs, suggest that three different forms of LGRs
named (A, B, and C) emerged during early metazoans evolution (Hsu, 2003) (Table 2.1).
LGRs are mosaic proteins similar in structure to the glycoprotein hormone receptors (Hsu
et al., 2000); containing an ectodomain or extracellular domain with several leucine-rich
repeats (LRRs), that are considered to play an important role in ligand binding, due to
their seven-transmembrane spanning GPCRs. Similarly, each subtype of LGRs shares a
singular hinge region, located between the transmembrane region and the LRR (Hsu,
2003). RXFP1 (LGR7) consists of 757 amino acids (Hsu, 2002), while RXFP2 (LGR8) is
made of 737 amino acids in length, which contain 10 leucine-rich repeats in their large Nterminal extracellular domain, and they both share an amino acid sequence homology of
about 60% (Overbeek et al., 2001).
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RXFP1 and RXFP2 belong to the type C LGRs (Hsu et al., 2005) (Table 2.1).
Type C LGRs are characterized by a low-density lipoprotein class A (LDLa) module at
the N-terminus, which is followed by an alternatively spliced flanking region, and
ultimately the LRRs. At the end of each LRRs, there is a structure that has been
denominated as “caps” (cysteine-rich regions). In several proteins, these caps have been
shown to be an essential part of the LRR (Kobe and Kajava, 2001). The signaling
pathway of type C LGR is considered to be one of the earliest pathways of GPCR
signaling. The seven-transmembrane-spanning GPCR region is the structure located in
the middle of the C-terminal tail and the ectodomain (Hsu et al., 2002).
Table 2.1

Multiple GPCR signaling pathways with coupling of relaxin family
peptides. Re-drawn from Hsu et al. (2005)

RECEPTORS
LIGANDS
FSHR
FSH
LHR
LH
TSHR
TSH
Type B
LGR 4
----LGR 5
----LGR 6
----Type C
RXFP 1
Relaxin 1, 2, INSL 7
RXFP 2
Relaxin 1, 2, INSL 3
N-C
RXFP 3
INSL 7
RXFP 4
INSL 5; INSL 7
(----) Orphan receptors; (N-C) Non-Classified receptors.
Type A

Conservation of these two receptors (RXFP1 and RXFP2) is high across species.
For instance, between humans and rodents, the sequence similarity observed was more
than 90% (Hsu et al., 1998; 2002; 2003). According to Hsu (2003), both receptors
contain N-linked glycosylation sites and promote cAMP accumulation through activation
of adenylate cyclase, as well as stimulate PKA signaling mechanism.
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2.2.4

RXFP3 and RXFP4
Much less is known about these two receptors in comparison to RXFP1 and

RXFP2. The RXFP3, which is also known as somatostatin and angiotensin-like peptide
receptor and RXFP4 are also G-protein-coupled receptors (Bathgate et al., 2006) and
have been proposed to be the putative receptors for relaxin-3 (Liu et al. 2003a, b).
However, later experiments have demonstrated that RXFP4 is perhaps the receptor for
INSL5 (Liu et al. 2005). In contrast to RXFP1 and RXFP2, the two following receptors
RXFP3 and RXFP4 belong to the type I family of GPCRs, which possess a short Nterminal extracellular domain. Apparently, these receptors interact exclusively with the
inhibitory subunit G protein α (Gαi) to inhibit cAMP, while RXFP1 and RXFP2 act
through the stimulatory G protein α (Gαs) to increase cAMP through activation of
adenylate cyclase (Liu et al. 2003a, b). RXFP3 has 469 amino acid residues, while
RXFP4 possesses 374 (Bathgate et al., 2006). These two receptors (RXFP3 and RXFP4)
share an amino acid sequence identity of about 43% (Liu et al. 2003a).
2.3

Analysis of sperm motility: Use of the Computer Assisted Sperm-Analysis
(CASA) approach
Sperm motility is considered as one of the most important parameters for

determining the fertility capacity of an individual male. However, the use of microscopic
equipment to assess such characteristic is not well correlated with either in vitro or in
vivo fertilization rates (Zaini et al. 1985; Liu et al., 1988a). This limited correlation is not
only due to human errors while employing a subjective method for assessment of sperm
movement, where high coefficient of variations have been reported between technicians
(44%), but also within technicians (33%) (Dunphy et al. 1989), which is confounded by
the equipment limitations, used for determination of detailed sperm movement patterns.
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Improvement in this field had been impeded by the dearth of an objective system for
motility assessment (Mack et al., 1988). Sperm motility was usually determined
employing semi-objective or highly subjective techniques that establish motility on a
routine basis. On the other hand, several studies have reported that technical variability
can be diminished when employing an objective method (Katz and Overstreet, 1981),
besides several sperm movement characteristics can be determined as well (individual
cell kinematics), that could be potentially of great importance (Mack et al., 1988).
Thus, new systems such as the Computer Assisted Sperm-Analysis (CASA) have
been developed seeking for solution of the previous inconveniences just mentioned. The
CASA equipments were initially available during the mid-1980s (Aitken et al., 1985;
Katz et al., 1986; Jeulin et al., 1986). Nevertheless, the consensus about the role of
CASA is divided. Although there has been an optimistic and determined action to
establish the role of CASA in both the research and clinical andrology laboratory
(Oehninger et al., 2000), others have said that because of the higher number of sperm
motility parameters assessed by CASA, it does imply more accuracy in the prediction of
fertility (Hirano et al., 2001).
Several CASA systems have been developed, and the technique employed for the
tracking and identification of sperm cells varies among them. For instance, the Hamilton
Thorne CASA instrument identifies sperm cells through the location of the brightest
region of every bright object (Yeung et al., 1992); while some other systems (e.g.
CellSoft) determine the head of the sperm cells as a group of pixels, and then estimate the
center of this series of pixels, that is considered as the centroid (Berns and Berns, 1982).
The CellTrak system (Motion Analysis) determines the centroid of the sperm head as
well based on the pixels which delineate the edge of an object (Boyers et al., 1989).
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Besides the different methods employed by each CASA system to track and identify
sperm cells, the sperm motility parameters given by the systems can vary as well. For
instance, there are some parameters that are not universally acquired and obviously not
reported by all CASA equipments. However, there are some other sperm movement
parameters that are determined by all CASA apparatus (Mortimer, 1997), as follow (see
also Figure 2.1):

2.3.1

General sperm motility parameters

1. Total number of sperm cells.
2. Percentage of motile spermatozoa (%).
3. Percentage of progressive spermatozoa (%).
4. Number of rapid spermatozoa (≥ 45 µm/s) (speed’s threshold determined by
researchers).
2.3.2

Velocities

1. VCL (Curvilinear velocity, µm/s) = is the velocity of progression following the
entire sperm trajectory (Figure 2.1).
2. VAP (Average path velocity, µm/s) = is determined from an average path
smoothed trajectory by five-point, running average of the centers of brightness
(Figure 2.1).
3. VSL (Straight line velocity, µm/s) = is determined from the distance among the
first and last track points (Figure 2.1).
2.3.3

Progression ratios
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2.3.4

LIN (Linearity, %) = VSL/VCL x 100.

(2.1)

STR (Straightness, %) = VSL/VAP x 100.

(2.2)

Head movements

1. BCF (Beat cross frequency, Hz) = frequency that the sperm head crosses the
smoothed trajectory.
2. ALH (Amplitude of lateral head displacement, µm) = mean lateral sperm head
displacement throughout the smoothed trajectory (Figure 2.1).

Figure 2.1

Different track speed and movement of spermatozoa measured by the
Hamilton-Thorn Motility Analyzer. Velocities (µm/s): Curvilinear velocity
15

(VCL); average path velocity (VAP); straight line velocity (VSL).
Progression ratios (%): linearity (LIN = VSL/VCL x 100); straightness
(STR = VSL/VAP x 100). Head movements (µm): amplitude of lateral
head displacement (ALH). Re-drawn from Liu et al. (1991).
2.4

Relaxin hormone and the second messenger cyclic adenosine 3’, 5’monophosphate in sperm motility
Some of the physiological answers to several biologically relevant or important

compounds are carried out through “second messengers”. This term was introduced and
described by Sutherland et al. (1968) for the type of molecules able to exert
intracellularly, the biological response of substances or compounds that are not allowed
to enter the target cells by them. Cyclic adenosine 3’, 5’-monophosphate (cAMP or cyclic
AMP) is considered as one of the most important ‘second messengers’ involved as a
mediator of several physiological processes, and signaling cascades through the action of
several neurotransmitter and hormone receptor complexes. The binding of
neurotransmitters and hormones occur throughout specific receptors that are coupled with
G-proteins. Therefore, the already activated G-proteins regulate the action of the complex
membrane-bound adenylyl cyclase that promotes the conversion of cytoplasmic ATP to
cAMP (Beavo and Brunton, 2002).
In the same way, the actions of relaxin hormone after stimulation of RXFP1
receptor involve accumulation of cAMP (Halls et al., 2006). Although relaxin was
discovered almost a century ago, the identification of its cognate receptor RXFP1 was not
possible until the past 10 years. Since then, research has increased its understanding of
the different paths on how relaxin and its receptors are acting. In some cell culture-based
bioassay systems the actions of the peptide hormone-receptor compound have been
determined. This is the case of the human monocyte cell line THP-1 and the primary
human endometrial stromal cells from the cycle (ESC), where a rapid increase in cAMP
16

accumulation was evidence after activation with relaxin (Bartsch et al., 2001). The same
cAMP increase was observed when using the human embryonic kidney (HEK) 293T cells
(Halls et al., 2006). On the other hand, as far as we know, there is not any study showing
any cAMP increase and/or modification in sperm cells after treatment with relaxin.
However, Miah et al. (2006) have hypothesized that, although the mechanism of relaxin
actions for inducing acrosome reaction and increasing sperm motility are not well
understood, it might be thought that relaxin is acting by increasing the intracellular cAMP
levels. These increased levels in cAMP might be responsible for inducing acrosome
reaction and enhancing sperm motility.
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CHAPTER III
PRELIMINARY STUDY
3.1

Abstract
Three boar sperm concentrations (50, 75 and 100x106 boar sperm cells) were used

in a preliminary study to establish the optimal sperm concentration that would provide a
number of spermatozoa between 200 to 400 per sample for analysis with CASA. Motile
spermatozoa were selected through a discontinuous percoll. Then, 3µL of Boviextendsuspended motile spermatozoa were loaded in caffeine-free Leja chamber slides, and then
placed into CASA. Data were analyzed using the GLM procedure in SAS. Then, Tukey
test was used to establish significant differences between means (P < 0.05). The 75 x 106
boar sperm concentration provided the required amount of cells for CASA analysis. We
also obtained the percentage of motile and progressive spermatozoa, as well as VSL and
VCL (µm/s). Having determined the optimal concentration, all settings (for equipment)
and conditions (for sperm cells) were ready to be used for the study of relaxin effects on
sperm motility.
Key words: boar semen, CASA system, kinematic parameters, sperm
concentration
3.2

Introduction
Analysis of spermatozoa is commonly carried out employing subjective methods

in which a trained technician judges the sample under his/her own criteria using a
microscope under which sperm cells are placed for analysis. When employing these
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methods, sperm motility (%) can be determined based on the speed and straightness of
sperm on a routine basis, as well as a motility index estimated with reasonable accuracy
among technicians (Liu et al., 1988a). Nevertheless, according to the World Health
Organization (1987), the categories can not be identified with exactitude, as well as this
type of analysis does not correlate well with either in vitro or in vivo fertilization (Zaini et
al., 1985; Liu et al., 1988a).
On the other hand, several objective methods have been developed, such as, semiautomatic image analysis (Holt et al., 1985), time-exposure photomicrography (Aiken et
al., 1982), cinemicrography (David et al., 1981), and videomicrography (Katz and
Overstreet, 1980). Even though, the used of these objective systems have not been widely
accepted in the clinical field (Liu et al., 1991), it has been proven that they are able to
provide objective measurements of sperm behavior in terms of motility, plus detailed
movement characteristics of semen that are not provided by subjective methods. Several
computer-assisted sperm motility analysis (CASA) systems have been developed, and
ample variety of sperm movement patterns can now be determined. Nonetheless, there
are some difficulties associated with the use of CASA, such as the lack of agreement with
regards to accuracy, precision and measurements provided by the system, which are
generally associated with the semen sample (specie, volume, etc.). High or low number
of sperm cells during each trial can contribute to misleading results. Thus, the aim of this
preliminary study was to determine the best starting sperm concentration that would
provide an adequate number of spermatozoa per sample (between 200 to 400 cells) to be
analyzed by CASA. These results would serve as a standard for further studies involving
the addition of porcine relaxin hormone to boar spermatozoa during storage.
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3.3
3.3.1

Materials and Methods
Boar sperm cells preparation
Four batches of pooled boar semen diluted in Beltsville Thawing Solution (BTS)

were employed. Semen was obtained at Prestage Farm (West Point, MS) and kept at
room temperature (18-21°C) during experimentation. Separation of sperm cells from BTS
was carried out by centrifugation at 1000 rpm (253 g) for 5 min at room temperature.
Then, selection of motile sperm cells was achieved by using a percoll gradient after a 30
min centrifugation at 600 g. Spermatozoa were resuspended in Boviwash medium and
recentrifuged at 253 g for 5 min. Finally, washed motile sperm were brought to 1 mL of
pre-warmed Boviextend medium and counted on a Hemacytometer (Improved Neubaver,
Buffalo, NY) chamber. Three different sperm concentration were used as follow: 50 x
106; 75 x 106 and 100 x 106 boar sperm cells/mL. Analysis were performed during three
consecutive days (1[day of boar sperm collection], 2, and 3), and BTS-diluted sperm cells
were kept at room temperature. Motile spermatozoa were freshly prepared each day.
3.3.2

Analysis of total boar spermatozoa cells and motility parameters
The number of sperm cells and motility was objectively analyzed using CASA

(HTM-IVOS Hamilton-Thorne Biosciences, Version 12.3. Beverly, MA). Briefly,
analyses of 3µl of Boviextend-suspended motile spermatozoa were loaded in caffeinefree Leja counting chamber slides (Standard Count 4 Chamber Slide Leja®, 20 micron,
Nieuw Vennep, The Netherlands) in triplicates, and placed into the CASA system set at
37ºC. Three separate fields were analyzed for a minimum of 200 spermatozoa per
sample. Experiments were repeated four times with different pools of semen (biological
replicates).
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3.3.3

Statistical Analysis
Data were analyzed using the GLM procedure. Then, Tukey’s test was used to

established significant differences between means, and P ≤ 0.05 was fixed as threshold of
significance (SAS® 9.2, Copyright (c) 2002-2008 by SAS Institute Inc., Cary, NC).
3.4

Results
With a CASA set up of three fields (number of sperm cells counted at three

different spots in the slide chamber), the two highest sperm concentrations (75 and 100 x
106 /mL) provided with the number of sperm cells in between the expected range (200400) (Figure 3.1). However, when using 100 x 106 sperm cells/mL, the number of
spermatozoa obtained was relatively close to the maximum limit range (400
spermatozoa), especially on days 1 and 3 of analysis (Figure 3.1). While using 50 x 106
sperm cells/mL, only on day 3 of experimentation the number of spermatozoa obtained
were in between the range, while during the first two days those values were below 200
sperm cells/sample (Figure 3.1).
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Figure 3.1

Total number of sperm cells obtained by CASA when using three different
sperm concentrations (50, 75 and 100 x 106 boar sperm cells/mL) during
three consecutive days (1, 2, and 3) of storage. Data are shown as mean
values ± SEM. Significant differences (P < 0.05) within the same day are
indicated by different letters (a, b, c).

We also measured other kinematic parameters such as motility, progressiveness of
sperm, VSL and VCL.
The mean percentage of motile spermatozoa (%, obtained from the total number
of sperm cells) are shown in figure 3.2. As expected, the higher the sperm concentration,
the higher the percentage of motile spermatozoa. However, on day three of analysis the
percentage of motile spermatozoa obtained when using a concentration of 75 x 106 sperm
cells/mL was lower compared to the one obtained using 50 x 106 sperm cells/mL,
although there was not significant difference between sperm concentration. Conversely,
on days 1 and 2 of analysis there was a significant difference between the lowest sperm
concentration (50 x 106/mL) and the highest relaxin dose (100 x 106 /mL).
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Figure 3.2

Motile spermatozoa obtained by CASA when using three different sperm
concentrations (50, 75 and 100 x 106 boar sperm cells/mL) during three
consecutive days (1, 2, and 3) of storage. Data are shown as mean
percentage (%) ± SEM from the total number of sperm cells. Significant
differences (P < 0.05) within the same day are indicated by different letters
(a, b, c).

With regards to the percentage of progressive spermatozoa, it was observed that
the higher the sperm concentration, the higher the percentage of progressive spermatozoa.
There were no significant differences between sperm concentrations in none of the three
different days of analysis (Figure 3.3)
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Figure 3.3

Progressive spermatozoa obtained by CASA when using three different
sperm concentrations (50, 75 and 100 x 106 boar sperm cells/mL) during
three consecutive days (1, 2, and 3) of storage. Data are shown as mean
percentage (%) ± SEM from the total number of sperm cells. There were not
significant differences (P < 0.05) within the same day between sperm
concentrations.

The straight line velocity (VSL, µm/s) (Figure 3.4) of spermatozoa was similar
between all three sperm concentrations on days 1 and 3, but VSL was significantly (P <
6

0.05) lower when using the lowest sperm concentration (50 x 10 ) on day 2.

With regard to the curvilinear velocity (VCL, µm/s) (Figure 3.5) of spermatozoa,
there were no significant differences (P < 0.05) across days of experimentations among
sperm concentrations.
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Figure 3.4

Straight line velocity (VSL, µm/s) of spermatozoa obtained by CASA
when using three different sperm concentrations (50, 75 and 100 x 106 boar
sperm cells/mL) during three consecutive days (1, 2, and 3) of storage.
Data are shown as mean values ± SEM. Significant differences (P < 0.05)
within the same day are indicated by different letters (a, b, c)
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Figure 3.5

3.5

Curvilinear velocity (VCL, µm/s) of spermatozoa obtained by CASA when
using three different sperm concentrations (50, 75 and 100 x 106 boar
sperm cells) during three consecutive days (1, 2, and 3) of storage. Data are
shown as mean values ± SEM (P < 0.05). There were not significant
differences within the same day between sperm concentrations.

Discussion
Following the completion of preliminary studies evaluating three different sperm

concentrations, it was determined that the most optimal boar sperm starting concentration
was 75 x 106 sperm/mL. This sperm concentration provided the required number of
sperm cells (between 200 and 400) to be analyzed per trial while employing CASA.
Although, results obtained using the highest sperm concentrations (100 x 106) also fell
down in between the established sperm cell range (between 200 and 400), this results
were slightly below the maximum range limit (400 sperm cells), especially on days 1 and
3 of analysis. For that reason, the risk of having a sample with more than 400
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spermatozoa while using a concentration 100 x 106 sperm cells/mL was high. So, when
analyzing a high number of sperm cells (above 400) with CASA, it might conduct to
misleading results. According to Davis and Katz (1993), the minimum number of motile
sperm cells to be analyzed should be at least 200 to obtain accurate estimates of
population means, and at least 300 motile spermatozoa should be analyzed to acquire
precise estimates of population distribution. For that reason, the 75 x 106 sperm/mL
concentration was employed in the following study involving the addition of porcine
relaxin hormone.
With resgard to the percentage of motile spermatozoa, it is one of the most
common parameters obtained by both subjective and/or objective methods. It has been
used as a parameter to evaluate quality of semen and fertility of males. In fact, motility of
sperm is considered as one of the main factors that correlates with fertility (Bostofte et
al., 1990). In addition, some studies have reported that motility of spermatozoa acquired
by CASA could be predictive of fertility (Aitken et al., 1985; Katz et al., 1986; Jeulin et
al., 1986; Liu et al., 1991). However, the information regarding the role of sperm motility
during fertilization is contradictory. Conversely, it has been shown that there is not a high
correlations between the fertilizing capacity of spermatozoa and its motility. One reason
by which sperm motiltiy estimates does not correlate well with fertilization is that
motility is not the only factor that spermatozoa must possess in order to fertilize an
oocyte (Graham, 2001). Motility is just one factor among the many that might be
influencing the fertilization process.
Besides of sperm motility, the percentage of progressive spermatozoa was also
determined. This is not only the sperm that is presenting any motility, but it is also the
sperm that is travelling in a forward progression manner. According to Björndahl (2010),
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inflamatory reactions and acute infections in the male reproductive tract can be evidence
through sperm cells with a reduced progressive (forward) motility. In the same way, the
importance of progressive spermatozoa go beyond this point. For instance, in either in
vivo (Aitken et al., 1985) or in vitro (Hirano et al., 2001) studies, it has been evidenced
that spermatozoa presenting a progressive (forward) pattern of travel is required for
successful results, and has been considered as a useful indicator with in vivo fertilization.
One of the advantages of using CASA, besides of being an objective system, is
that it can break down motility in different parameters. For instance, it can track the the
different sperm movements and velocities in an ejaculate. This preliminary study also
shows information about different velocities such as VSL and VCL (µm/s). Knowing that
VSL, VCL, and VAP are parameters that explain spermatozoa velocities in diverse ways,
strong correlations have been found among them (Wijchman et al., 2001). VSL is
determined from the distance among the first and last track points of a sperm trajectory
(Figure 2.1). Some studies have found strong correlations in humans between VSL and
fertilization rates in vitro, concluding that sperm cells travelling in a straight line manner
conjugated with speed (faster sperm) have a higher probability of achieving its goal,
fertilization of the female gamete (Liu et al., 1991). With respect to the VCL, defined as
the total trajectory travelled by the sperm head, some studies have found this velocity in
human samples related to in vitro fertilization (IVF) rates (Holt et al., 1985).
3.6

Conclusions
Our preliminary study indicated that a concentration of 75 x 106 boar sperm

cells/mL provided the required amount of sperm cells by CASA to obtain accurate
results. This sperm concentration (75 x 106 boar sperm cells/mL) was employed in the
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following experiments involving addition of different porcine relaxin hormone
concentrations to boar spermatozoa during storage to evaluate its effects on motility using
CASA.
On the other hand, information reported about the different CASA estimates vary
greatly. Some studies have found correlations between sperm motility parameters with
either in vitro or in vivo fertility rates, while others have not. In the same way, research
has shown that some of these estimates can be considered as good predictors of fertilizing
abilities; however, some other research haven not. Although information and results vary
greatly, one might think that reasons for that are the different approaches, techniques,
experimental designs and obviously study purposes used to obtain such CASA estimates,
independently of the CASA equipment employed. Nonetheless, the usefulness of CASA
in determining motility sperm parameters is of great value. Accuracy of this system for
determining detailed information about sperm movement patterns (kinematics), as well as
establishing the paths calculated in different ways and speed of sperm cells is greater
compared to subjective methods. Further research is needed in order to determine the
functionality and implications of the different sperm movements with regards to the
fertilization process.
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CHAPTER IV
EFFECTS OF RELAXIN HORMONE ON MOTILITY CHARACTERISTICS OF
BOAR SPERMATOZOA DURING STORAGE
4.1

Abstract
The objectives of this study were to (i) determine the effect of relaxin on full

motility characteristics of boar spermatozoa during storage, using the Computer-Assisted
Sperm Analysis (CASA), (ii) identify the presence of RXFP1 and RXFP2 receptors on
boar spermatozoa and (iii) establish if relaxin promotes an intracytoplasmic cAMP
increase in boar spermatozoa. Motile spermatozoa were selected through a discontinuous
percoll gradient. Semen was incubated for 60 minutes at 37oC with 0, 50, 100 and 500
ng/mL pig relaxin during four different days (1, 2, 3, and 5). Relaxin positively affected
boar sperm motility parameters (P < 0.05). Relaxin receptors RXFP1 and RXFP2 were
found in boar sperm cells when employing an immunofluorescent assay. However,
intraspermatic cAMP levels were not affected by relaxin (P < 0.05). This study indicates
a beneficial action of relaxin on sperm motility; however its mechanism of action
requires further research.
Key words: relaxin hormone, semen, cAMP, sperm motility, storage.
4.2

Introduction
Relaxin is a small polypeptide of about 6 Kda discovered almost a century ago

and is well known as a hormone of pregnancy in many mammals (Hisaw, 1926;
Sherwood, 2004). Renowned by its role in parturition and other aspects of female
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reproduction, relaxin is also present in various reproductive and non-reproductive tissues
of both females and males (Sherwood, 2004). Relaxin family consists of several members
having pleiotropic roles in a variety of tissues and cells, including spermatozoa
(Sherwood, 2004).
The prostate gland appears as the major source of relaxin synthesis in males (Ivell
et al., 1989), and its secretions are found in seminal plasma (Lessing et al., 1986). Even
though, the physiological action of relaxin in spermatozoa is not well understood, in vivo
studies have shown positive correlations between the immunoreactive relaxin content of
boar seminal plasma and sperm motility (Juang et al., 1990), suggesting that relaxin
might have a role during sperm motility. This beneficial effect has been confirmed with
in vitro studies showing that addition of relaxin to boar and human spermatozoa
stimulates sperm motility (Juang et al., 1989; Colon et al., 1986), whilst addition of antirelaxin antiserum restrained this effect (Juang et al., 1989). It has been proposed that
relaxin actions are accomplished through specific receptors. In fact, relaxin is the
endogenous ligand of the G-protein coupled receptor LGR7 that has been renamed as
RXFP1. In some species such as the human, relaxin can bind and activate, but with a
lower affinity, the closely associated receptor RXFP2 (previously known as LGR8) for
the insulin-like peptide from Leydig cells (INSL3) (Filonzi et al., 2007).
Subjective methods are generally employed for the determination of sperm
motility (Liu and Baker, 1988). The Computer-Assisted Sperm Analysis (CASA) systems
however, offer the possibility of determining several sperm movement characteristics in
an objective manner (Mack et al., 1988). The use of CASA has allowed for an important
advancement in the research of sperm biology, especially with regard to sperm
hyperactivation (Lamirande and Gagnon, 1993). Given the beneficial role of relaxin
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hormone on sperm motility, the potential of relaxin to extend motility lifetime of
spermatozoa during storage would be of great interest for the swine breeding industry and
pork producers.
Therefore, the objective of this study was to determine the effect of relaxin on full
motility characteristics of boar spermatozoa during storage. Firstly, we analyzed the boar
sperm motility using (CASA). Secondly, we assessed the presence of relaxin receptors
(RXFP1 and RXFP2) on boar sperm cells using an immunofluorescense approach.
Thirdly, the relaxin effect on intraspermatic cyclic AMP was evaluated.
4.3
4.3.1

Materials and Methods
Semen Samples
Four batches of (pooled of 2-4 boars each batch) boar semen diluted in Beltsville

Thawing Solution (BTS) were obtained at Prestage Farm (West Point, Mississippi) and
kept at room temperature (18-21°C). Sperm cells were separated from the BTS by
centrifugation at 1000 rpm (253 g) for 5 min at room temperature. Motile sperm were
purified using a discontinuous percoll gradient after a 30 min centrifugation at 600 g.
Sperm were resuspended in Boviwash (Nidacon products, Mölndal Sweden) medium and
recentrifuged at 253 g for 5 min. Washed motile sperm were resuspended in 1 mL of prewarmed Boviextend medium and counted on a Hemacytometer (Improved Neubaver,
Buffalo, NY). Spermatozoa were brought to a final concentration of 75 x 106 /mL (as
determined in the preliminary study) for treatments.
4.3.2

Semen Treatment
The action of porcine relaxin (pRLX), purified from pregnant sow ovaries

(Kohsaka et al., 1993) was evaluated on boar spermatozoa. The relaxin concentrations
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employed in this study (0, 50, 100, and 500 ng/mL) were selected based on preliminary
studies conducted by Miah et al. (2006) and Kohsaka et al. (2001), respectively.
According to Miah et al. (2006), the highest increases in progressive motility of boar
spermatozoa was observed when using 20 ng/mL and 40 ng/mL relaxin in comparison to
other relaxin concentrations as follow, 0, 10, 60, 80, and 100 ng/mL. However, Kohsaka
et al. (2001) in a dose response curve study found that the highest significant
improvements of relaxin in boar sperm motility was observed from 100 ng/mL to 1000
ng/mL, and picking at 100 ng/mL, among different relaxin concentrations as follow, 0, 5,
10, 25, 50, 100, 250, 500, 1000, 2500, 5000, and 10000 ng/mL. BTS-diluted sperm was
stored for up to 5 days at room temperature (18-21 ºC). In experiment 1, boar sperm was
daily prepared during 3 consecutive days (days 1 [day of sperm collection], 2 and 3).
Purified motile spermatozoa were incubated in the presence of various relaxin
concentrations: 0, 50, and 100 ng/mL. In experiment 2, boar sperm was prepared on day
5 of storage. Purified motile spermatozoa were incubated in the presence of relaxin at 500
ng/mL. In both experiments, incubation with relaxin lasted for 1 hour at 37oC. The time
of exposure of boar sperm cells to relaxin was determined based on the study conducted
by Miah et al. (2006). They evidenced that the highest impact of relaxin on progressive
motility of boar sperm was around 1 hour of incubation compared to other time periods,
0, 1, 2, 3, 4, 5, 6 hours. Treated spermatozoa were then used for analysis of sperm
motility.
4.3.3

Analysis of Sperm Motility
Sperm movement characteristics were objectively analyzed using CASA (HTM-

IVOS Hamilton-Thorne Biosciences, Version 12.3. Beverly, MA). Briefly, 3µl aliquot of
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treated sperm samples were placed in caffeine-free Leja counting chamber slides
(Standard Count 4 Chamber Slide Leja®, 20 micron, Nieuw Vennep, The Netherlands) in
triplicates and placed into the CASA equipment set at 37ºC. Three separate fields were
analyzed for a minimum of 200 spermatozoa per sample.
The following parameters were considered: total cell count (counted cells),
percent of motile cells (%), percent of progressive cells (%), percent of rapid cells (%, ≥
45 μm/s), average path velocity (VAP, µm/s), straight line velocity (VSL, µm/s),
curvilinear velocity (VCL, µm/s), amplitude of lateral head displacement (ALH, µm),
percentage of straightness (STR; VSL/VAP), and the percentage of linearity (LIN; VSL/
VCL). The CASA settings were adjusted according to manufacturer’s instructions.
4.3.4

Immunofluorescence Detection of RXFP1 and RXFP2 on Boar
Spermatozoa
After treatments, sperm cells were pelleted through centrifugation at 253 g for 5

min, and resuspended in 1 mL of cold PBS for relaxin receptors detection. Resuspended
sperm cells were spread out on Poly-lysine microscope slides (Erie Scientific Company,
Portsmouth, NH), and air-dried. Slides were incubated in 4% formaldehyde solution for
30 min at 37ºC, followed by two washes in PBS for 5 min each at room temperature
(~21°C). Slides were incubated for 1 hour at room temperature with 10% (v/v) normal
goat blocking serum (PBS-PVP), followed by incubation with RXFP1 (H-160; sc-50328)
or RXFP2 (H-150; sc-50327) (Santa Cruz Biotech Inc. Santa Cruz, CA) antibodies [1:100
dilution in PBS-PVP + 0.1 % Tween 20]. After a 4 h incubation period at room
temperature, slides were washed 3 times in PBS-PVP + 0.1% Tween 20 for 5 min each
time, and incubated with the secondary antibody (goat anti-rabbit IgG-FITC; sc-2012;
1/200 dilution in PBS-PVP) for 1 h at room temperature. Slides were washed 3 times
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with PBS-PVP + 0.1% Tween 20 for 5 min each time. Then, boar sperm cells were
counterstained with DAPI dye and placed under a confocal microscope for analysis.
Fluorescent images were acquired using a Zeiss LSM 510 Confocal Laser Scanning
Microscope (Carl Zeiss Microimaging, Inc) with an Inverted Zeiss Axiovert 200 M Light
microscope and a plan apochromat 100 X/1.4 NA objective lens. A
(DAPI/Fluorescing/Transmission) filter set was used in Single channel mode imaging.
Excitation wavelengths of 405nm/488nm and Band Pass Emission wavelengths of 420480 nm (Blue) and Long Pass wavelengths of 505nm (Green) were acquired at
1024x1024 pixel format for imaging purposes. Sperm without primary antibody were
used as a negative control. All procedures were performed at room temperature, unless
otherwise indicated.
4.3.5

Measurement of cAMP Content in Boar Spermatozoa
After treatments, sperm cells (75 x 106/mL) were pelleted through centrifugation

at 253 g for 5 min, and stored at -20ºC until further processing. The assay was performed
as recommended by the manufacturer (Assay Designs Inc., cyclic AMP (DIRECT), Ann
Arbor, M). Briefly, frozen-thawed spermatozoa were lysed in 0.1 M HCl during 30 min
at room temperature (~21°C), and cell debris were eliminated after centrifugation (600 g
for 15 min at room temperature). Supernatant was recovered and used immediately for
acetylation. Intraspermatic cAMP concentrations were determined in 100 µL of sample,
corresponding to 7 x 106 sperm cells.
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4.3.6

Statistical Analysis
Data were analyzed using a Two-way ANOVA, followed by Fisher’s LSD test,

and a P ≤ 0.05 was fixed as threshold of significance (SAS® 9.2, Copyright (c) 20022008 by SAS Institute Inc., Cary, NC).
4.4
4.4.1

Results
Sperm motility
The effects of 0, 50, and 100 ng/mL relaxin concentrations on boar sperm motility

characteristics are summarized in Table 4.1. Data are mean percentages of motile cells
from total sperm cells ± SEM assessed by CASA. As expected, sperm motility
significantly decreased with storage from day 1 through 3 in the control group (P < 0.05).
Both 50 and 100 ng/mL relaxin doses significantly increased the percentage of motile
spermatozoa on day 2 of storage compared to the control groups. However, the presence
of relaxin did not affect sperm motility on day 1 or day 3 of storage. Across time, 50 and
100 ng/mL relaxin doses kept sperm motility (days 1 and 2), although on day 3 motility
significantly decreased.
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Table 4.1

Effect of increasing relaxin concentration on boar sperm motility during storage.

Relaxin treatment
motile spermatozoa (mean %age of total cells ± SEM) on:
groups (ng/ml)
Day1
Day2
Day3
a¥
a§
0
62.7 ± 2.7
58.5 ± 2.5
54.1 ± 3.2a€
a¥
b¥
50
65.3 ± 2.9
62.3 ± 2.5
57.1 ± 2.9a§
100
65.4 ± 2.3a¥
66.1 ± 1.9c¥
56.8 ± 3.1a§
Significant differences (P < 0.05) within the same column and row are indicated by different
letters (a, b, c) and symbols (¥, §, €), respectively. Data are mean values ± SEM of 4 independent
experiments.
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Analysis of the relationship between the addition of relaxin and boar progressive
spermatozoa is shown in Figure 4.1. Addition of 50 and 100 ng/mL relaxin increased the
percentage of progressive spermatozoa on each day of the experiment as compared to the
control treatments.

Figure 4.1

Effect of porcine relaxin on proportion of progressive sperm. Data are
shown as mean percentage (%) ± SEM from the total number of sperm
cells. Significant differences (P < 0.05) within the same day are indicated by

different letters (a, b).

The proportion of rapidly moving spermatozoa (sperm traveling at 45 µm/sec or
more) is shown in Figure 4.2. The addition of 100 ng/mL relaxin on day 1 increased the
percentage of rapidly moving spermatozoa (P < 0.05). On day 3 of storage, 50 ng/mL
relaxin increased rapid sperm. On the other hand, there was not effect with any of the
relaxin doses used during the second day of storage.
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Figure 4.2

Effects of relaxin on rapidly moving spermatozoa (≥ 45 µm/sec) during
storage. Data are shown as mean percentage (%) ± SEM from the total
number of sperm cells. Significant differences (P < 0.05) within the same day
are indicated by different letters (a, b).

With regard to the straight line velocity (VSL), the action of both the two highest
relaxin doses (50 & 100 ng/mL) had a significant effect (P < 0.05) during the first two
days of storage, while there was no effect on day 3 (Table 4.2). Across time, there was an
increased of VSL of sperm when using 50 ng/mL relaxin as well as in the control group
compared to day 1 of storage.
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Table 4.2

Effect of an increasing relaxin concentration on the straight line velocity
(VSL) of boar spermatozoa during storage.

Relaxin
Spermatozoa VSL (mean μm/s ±SE) on:
treatment
groups (ng/ml)
Day1
Day2
Day3
a¥
a§
0
48.0 ± 1.9
52.7 ± 1.7
53.7 ± 2.5a§
b¥
b§
50
53.2 ± 3.0
57.5 ± 2.0
57.0 ± 2.4a§
b¥
b¥
100
57.1 ± 2.1
58.6 ± 1.2
56.9 ± 2.3a¥
Significant differences (P < 0.05) within the same column and row are indicated by
different letters (a, b, c) and symbols (¥, §), respectively. Data are mean values ± SEM of 4
independent experiments.
The straightness (VSL/VAP x 100) of sperm is shown in Figures 4.3. Both 50 &
100 ng/mL relaxin significantly increased straightness of spermatozoa since the very first
day of analysis. It also was evidence that across time, there was a general decrease of
straightness. However, the presence of porcine relaxin reduced (P < 0.05) the decrease in
percentage of sperm straightness on the last two days of storage in comparison with the
control group.
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Figure 4.3

Effects of porcine relaxin on the straightness (STR, % = VSL/VAP x 100)
of spermatozoa. Data are shown as mean (%) values ± SEM. Significant
differences (P < 0.05) within the same day are indicated by different letters

(a, b).

Results about linearity (VSL/VCL x 100) of sperm are shown in figure 4.4. It also
was noticed that across time, there was a general decrease of linearity as the one observed
in the previous ratio (straightness, Figure 4.3). However, the presence of porcine relaxin
reduced (P < 0.05) the decrease in percentage of sperm linearity on the last two days of
storage in comparison with the control group; so, there was a greater percentage of sperm
traveling more linear. On day 1 of analysis, relaxin did not influence any significant
change on the linearity of spermatozoa.
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Figure 4.4

Effects of porcine relaxin on the linearity (LIN, % = VSL/VCL x 100) of
spermatozoa. Data are shown as mean (%) values ± SEM. Significant
differences (P < 0.05) within the same day are indicated by different letters

(a, b).

4.4.1.2

Effects of a high relaxin dose
Relaxin at a concentration of 100 ng/mL appears to be the concentration with

higher effects on the general motility of boar sperm during storage. However, there was a
particular trend when using such concentration in some of the results obtained. There was
a general increased in the mean percentage of motile spermatozoa (Table 4.1) during days
1 and 2 of storage when using the highest relaxin dose (100 ng/mL). However, such
increase was not evidence on day 3 of storage. Due to this lack of effect by relaxin during
the last day of analysis one question arose, and it wass whether or not such lack of effect
on day 3 could had been due to a minute amount of relaxin remaining in the sperm
storage medium. Therefore, a higher relaxin (500 ng/mL) dose was employed to
determine its effects on sperm motility parameters.
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Table 4.3 summarizes the second trial carried out using a high relaxin dose (500
ng/mL) employed on day 5 of storage. Significant increases (P < 0.05) were evident in
some of the general motility parameters such as progressive sperm cells (%), and rapid
cells (%), as well as on the average path (VAP, μm/s), straight line (VSL, μm/s) and
curvilinear (VCL, μm/s) velocities. With regards to the progression ratios, linearity was
the only one positively affected (P < 0.05) by relaxin. However, the high porcine relaxin
dose did not have a significant effect either on motile sperm cells (%), amplitude of the
lateral head displacement (ALH, μm) or straightness (VSL/VAP, %).
Table 4.3

Effect of relaxin hormone (500 ng/mL) on full motility parameters of boar
sperm on day 5th of storage.

Storage
Relaxin Treatment

Day 5
0 ng/mL
Mean ± SE

Day 5
500 ng/mL
Mean ± SE

Parameters
*Motility (%)
66.8 ± 2.6a
68.3 ± 1.4a
**Progressive (%)
51.4 ± 1.9a
58.0 ± 1.2b
a
**Rapid (%)
68.4 ± 1.9
75.1 ± 1.2b
a
VAP (μm/s)
80.5 ± 2.3
90.2 ± 1.5b
VSL (μm/s)
51.5 ± 1.8a
57.6 ± 1.4b
a
VCL(μm/s)
175.0 ± 3.6
183.7 ± 2.3b
ALH (μm)
7.5 ± 0.1a
7.4 ± 0.1a
a
STR (VSL/VAP, %)
61.0 ± 0.9
61.4 ± 0.7a
LIN (VSL/VCL, %)
29.6 ± 0.6a
31.7 ± 0.6b
(*)Motile (mean percentage of total cells); both (**) progressive and rapid (mean
percentage of motile cells). Significant differences (P < 0.05) between columns are
indicated by different letters (a, b). Data are mean values ± SEM of 4 independent
experiments.
4.4.2

Immunofluorescense detection of RXFP1 and RXFP2
The identification of relaxin receptors (RXFP1 and RXFP2) on boar spermatozoa

employing an immunofluorescense approach are shown in Figure (4.5, Panels A-F). The
relaxin receptor RXFP1 (Panels C and D) was present in the head, neck, and intermediate
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piece of the tail in boar sperm, where it appears with a bright light emission, compared to
the negative control (Panels A and B). In the same way, RXFP2 receptor (Panels E and F)
was also noticed to be present in the same regions as RXFP1, but with a higher intensity.

Figure 4.5

4.4.3

Determination of relaxin receptors RXFP1 (Panels C and D) and RXFP2
(Panels E and F) on boar spermatozoa. Negative control (Panels A and B).
Pictures on top with FITC staining only (Panels A, C and E). Pictures at the
bottom with FITC and DAPI stainings (Panels B, D and F).

Measurement of cAMP content in boar spermatozoa
As shown in Figure 4.6, relaxin did not promote any significant increase of

intraspermatic cAMP content in boar spermatozoa through storage. Although, not
statistically significant, when boar sperm cells were incubated with relaxin (100 and 500
ng/mL), the cAMP content was slightly higher compared to the control on day 1 and 2 of
storage. On the other hand, on day 3 of storage, the content of intraspermatic cAMP was
even slightly higher in the control compared to the treated groups, but not statistically
significant either.
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Figure 4.6

4.5

Intraspermatic cAMP content in boar sperm cells after supplementation
with relaxin through storage. Data are shown as mean percentage (%) ±
SEM. There were not significant differences (P < 0.05) within the same
day of storage between relaxin treatments.

Discussion
The action of various porcine relaxin hormone concentrations on full motility

parameters of boar spermatozoa was assessed during storage, using CASA. The current
study indicates that porcine relaxin can keep and even increase boar sperm motility
during storage. As anticipated, sperm motility was significantly decreased during storage
in the control group; but a significant increase of the motility rate was evidenced on day 2
of sperm storage, when using relaxin at 50 and 100 ng/mL (Table 4.1); however, we did
not find any significant (P < 0.05) effect of relaxin at 500 ng/mL at day 5 of storage on
the motile sperm (Table 4.3). In accordance with our results, some studies have reported
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beneficial effects of relaxin hormone on sperm motility (Miah et al,. 2006; Juang et al.,
1989).
Besides sperm motility, we also noticed a positive effect of relaxin with all
concentrations employed in the proportion of progressive spermatozoa determined by
CASA during all days of storage. Juang et al. (1989) in a similar study reported
beneficial actions of relaxin on the progressively moving sperm when using 1000, 333,
and 167 ng/mL relaxin on fresh semen after 80, 120 and 180 minutes incubation
compared to the control group. Our study showed also positive effects using lower
concentrations of relaxin (50 and 100 ng/mL) on fresh semen after 60 minutes of
incubation with the peptide compared to the control group. Their (Juang et al., 1989)
initial percentage of progressively moving spermatozoa was higher than ours in the
control group (around 60% vs. 23%, respectively); however, our value appears relatively
lower compared to them because it was obtained from the total number of sperm cells,
and not from the motile sperm cell population as they did. Their results showed that after
80, 120 and 180 minutes incubation with the peptide, it significantly attenuated the loss
of motile progressively moving spermatozoa (%, between 40 and 50%) compared to the
control group (around 35%). In our case, compared to the control (23%), after 60 minutes
of incubation with relaxin at 50 and 100 ng/mL, it augmented the progressively moving
spermatozoa to 28 and 32%, respectively. On the other hand, Juang et al. (1989) also
studied the effect of relaxin in boar spermatozoa stored up to 5 days at 12°C. They found
that when adding relaxin at 1000 ng/mL just before storage (day 0, sperm collection), it
significantly attenuated the lost of progressively moving sperm (%) at 1.5, 2, 3, 3.5, 4 and
5 days compared to the control. Although, they observed a reduction in progressively
moving sperm during the first 10 hours of storage in both control (57%) and treated cells
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(around 64%) group compared to the initial percentage of progressive sperm (around
75%), this reduction was not significant (P > 0.05) between these two groups. Our study
also noticed the positive effects of relaxin when using lower concentrations (50 and 100
ng/mL) on days 1 (day of sperm collection), 2, and 3 of storage compared to the control.
Also, with a higher relaxin dose (500 ng/mL) on day 5 of storage we found positive
effects in the progressively moving sperm compared to the control. In this trial, their
(Juang et al., 1989) initial percentage of progressively moving spermatozoa also was
higher than ours in the control group (around 75% vs. 23%, respectively). However, on
day 5 of storage their results showed that the percentage of progressively moving
spermatozoa dropped to around 45%, while in their control dropped to around 35%.
When compared to our higher relaxin dose (500 ng/mL) on day 5 of storage, there was a
significant effect of the peptide in comparison to our control (58% vs. 51%). In
comparison to their study (Juang et al., 1989) on day 5 of storage, our values where
higher in both controls (51% vs. 35%) and treated groups (58% vs. 45%). However, in
this particular case (using 500 ng/mL relaxin on day 5 of storage) we obtained the
percentage of progressively moving spermatozoa from the percentage of motile
spermatozoa, and not from the total sperm cells as we did previously. In contrast to Juang
et al. (1989) study, where they added relaxin just before the whole storage period, we
daily prepared aged sperm cells and incubated them with relaxin 1 hour before motility
parameters were assayed. On the other hand, we kept spermatozoa at room temperature
(18-21°C) during the whole storage period, different from them that stored spermatozoa
at 12°C. According to Tash and Mann (1973), slow cooling to 0°C or 5°C can promote a
state of reversible inhibition of sperm motility. Based on this, we think that storage of
spermatozoa at 12°C as they did (Juang et al., 1989) might promote some inhibition of
47

sperm motility, which is translated into a slower consumption of energy reservoirs, due to
the reduced sperm motility. So, we assume that relaxin utilization was slower, knowing
that sperm motility was reduced due to the cooling conditions (12°C), and maybe that is
why they observed the highest effects of relaxin as time passed compared to the controls
even though they added the peptide just at the beginning of storage. In contrast to them,
we added relaxin to boar spermatozoa stored at room temperature (18-21°C) and
incubated them with the peptide for 1 hour at 37°C before motility assessment was
conducted with CASA. It means Juang et al. (1989) required the use of a refrigerator set
up at 12°C, which in not all cases is feasible to obtained one. From a production point of
view, one less equipment (a refrigerator) can be a factor that can change the farmers’
mind to adopt or ignore a new approach in their production system. Besides this, we used
lower relaxin concentrations compared to them (Juang et al., 1989) and still got positive
results. Due to the high cost of relaxin, this is another factor that might influence farmers’
minds before making the decision about whether or not they can use relaxin in their herds
to maximize the use of boar semen. On the other hand, one more major difference
between these two studies was the employment of different methods to determine the
progressively moving spermatozoa. Juang et al. (1989) established it using a transmembrane migration ratio (TMMR), which is basically the number of spermatozoa that
are travelling across a membrane that has micropores slightly bigger that the sperm
heads. Although, it is an objective system (TMMR), it just can determine motility on a
routine basis. The fraction of spermatozoa making it through the membrane has been
correlated with the progressively moving sperm (%) (Hong et al., 1981; 1985). In our
case, sperm motility was determined using another objective system, CASA, which can
determine besides motility, several sperm movement parameters, velocities and ratios.
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CASA can track the exact motility patter of sperm movement. Due to this variation in
methods employed, we also should expect variations when comparing results.
In addition, rapid spermatozoa were also positively affected by the peptide.
Several studies have shown that porcine relaxin has a stimulatory action not only on the
progressive spermatozoa, but also in the rapid sperm of boar sperm (Kohsaka et al., 2001;
Sasaki et al., 2001; Juang et al., 1990; 1989). Similar actions have also been noticed in

humans when porcine relaxin was added to washed ejaculated sperm (Essig et al., 1982a;
Colon et al., 1986), as well as in thawed human sperm after cryoconservation (Lessing et
al., 1985), where progressive spermatozoa was positively affected, while there was a
reduction in the loss of sperm motility.
We also observed the beneficial action of porcine relaxin on the straight line
velocity (VSL) of sperm (defined as the velocity of sperm progression from one point to
a second one in a straight line, measured in µm/s). According to Liu et al. (1991), there is
a correlation between VSL and the fertilization rates (in vitro) consistent with the
perception that sperm cells traveling with a faster straight line velocity have a higher
chance to fertilize an oocyte. Katz et al. (1982) showed that morphologically normal
spermatozoa swim straighter and faster than abnormal spermatozoa, therefore, explaining
why morphologically normal spermatozoa are considered as one of the most significant
sperm aspects associated to IVF rates (Katz et al., 1982; Kruger et al., 1986; 1988a, b;
Liu et al., 1988a; Liu et al., 1988b). Liu et al. (1991) reported a high correlation between
morphologically normal spermatozoa and the percentage of motile sperm showing
straightness higher than 80%, with an average path velocity (VAP) higher than 20
μm/sec. In the current studies, straightness was over 80% during the first day of
incubation when using porcine relaxin at 50 and 100 ng /mL (experiment 1); however, it
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was just significantly different when using 100 ng relaxin/mL compared to the control
group (P < 0.05) on day 1 (Figure 4.3). Additionally, Juang et al. (1989) also reported
that supplementation of sperm cells with antirelaxin serum abruptly reduced motility.
This study supports the idea that relaxin is essential as well as can improve motility of
sperm.
In addition to the relaxin effects on boar sperm motility, this study also reports the
presence of relaxin receptors RXFP1 and RXFP2 in boar spermatozoa. Therefore, it
might be possible that relaxin binds to specific membrane receptors to exert its effects on
spermatozoa. Carrell et al. (1995) conducted a study using 125I-labled human relaxin that
bound with high affinity to human spermatozoa, nevertheless, the determination of
specific human relaxin binding sites were not established. Additionally, Kohsaka et al.
(2001) reported the identification of specific relaxin binding sites on boar caudal
epididymal spermatozoa using an in situ binding histochemical assay, and provided
information that such binding has a significant action on sperm motility. Kohsaka et al.
(2001) found that relaxin bound with specificity to the tail and midpiece of sperm.
Additionally, bindings at the acrosome cap and neck of the head were also visible. Using
an immunofluorescense approach, our study shows the presence of relaxin receptors
(RXFP1 and RXFP2) in the head, neck and midpiece of boar sperm. It was noticed that
this presence was lower in RXFP1 receptor than in RXFP2. Although, we did not
quantify the amount of either RXFP1 or RXFP2 receptors in boar spermatozoa, our
results are in accordance with the findings reported by Feugang et al. (2011). They found
that after relaxin receptor proteins detection (western-immunoblotting), boar spermatozoa
exhibited lower RXFP1 signal than RXFP2. It suggests that boar spermatozoa are targets
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of relaxin, proposing that relaxin mechanism of action is first mediated through the
binding to its specific membrane receptors.
The present study also reported the actions of relaxin in the intracytoplasmic
content of cAMP of aged boar spermatozoa. After the ligand (relaxin)-receptor binding, it
is believe that relaxin promotes an intracellular signaling cascade that is leaded by the
second messenger cAMP. It is considered that addition of relaxin to the medium may
operate on G-proteins through relaxin receptors (Nistri and Bani, 2003), that have been
detected in the membrane of sperm cells by this study and others (Kohsaka et al., 2003)
using different means. Then, these G-proteins activate adenylate cyclase that in turn
increases the intracellular content of cAMP, and avoids the breakdown of it (cAMP) by
restraining the actions of cAMP phosphodiesterases (Bartsch et al., 2001), that are in
charge of the degradation of the second messenger. In the same way, it has been stated
that the nucleotide (cAMP) has an important task in the energy production required for
the sperm cells in its motility through the glycolytic pathway (Hicks et al., 1972).
Research has proposed that relaxin stimulates intracellular levels of cAMP in different
tissues such as uterus and cervix in the rat (Judson et al., 1980; Sanborn et al., 1980).
Although, some studies (Juang et al., 1989) have suggested that relaxin is increasing
sperm motility maybe through the alteration of intracellular cAMP after its binding to
surface receptors in spermatozoa, we do not know about the existence of any study that
has achieved this goal yet. So, this is probably the first study in doing so. However, we
did not observe any significant effect by any of the different relaxin concentrations
employed in the intracellular cAMP of aged boar spermatozoa. It can be that relaxin’s
mechanism of action on sperm motility might be driven in combination or activation of
cAMP-dependent protein kinases in the cytoplasm of spermatozoa instead of just cAMP.
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4.6

Conclusion
The present investigation indicates a valuable action of relaxin on several of the

boar spermatozoa movement parameters (e.g. motile, progressive and rapid sperm in the
general motility; VSL, and in the ratios of linearity and straightness) assessed with
CASA. This study also determined the presence of relaxin receptors (RXFP1 and
RXFP2) on boar spermatozoa membrane and suggests that relaxin peptide might activate
sperm motility through these specific receptors. However, this study did not see relaxin is
exerting any action on the intracellular cAMP content of boar sperm cells, what makes us
think that the relaxin’s mechanism of action may be driven in conjunction and/or
activation of cAMP-dependent protein kinases in the plasma membrane of sperm.
Therefore, further studies with regards to the relaxin intracellular mechanism of actions
on sperm motility need to be carried out.
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CHAPTER V
CONCLUSIONS
The study of sperm physiology and kinematics are of great importance in order to
understand the processes that can contribute to the acquisition of the best sperm to obtain
higher outcomes in terms of fertilization rates. A boar sperm concentration of 75 x
106/mL was determined to be as the optimal one to be employed while conducting
assessment of sperm motility with CASA. The attainment of such sperm concentration
was important, so accurate results can be obtained when employing CASA. Such sperm
concentration was employed while conducting studies involving the addition of relaxin
hormone to boar spermatozoa during storage.
The utilization of different substances such as relaxin hormone that can activate or
stimulate sperm motility can be much easily now study by using CASA. Relaxin at 50
and 100 ng/mL increased several of the sperm motility parameters in boar semen during
storage. For instance, the proportions of motile, progressive and rapid sperm in the
general motility, the VSL, and the ratios of linearity and straightness were positively
affected by the peptide. It would be of great importance if a method can be developed to
study every one of these sperm populations separately and see the implications they can
have in achieving higher outcomes in fertility rates. On the other hand, it would be
important to see if using relaxin hormone during a longer storage period (> 5 days) can
still increase further or at least maintained motility parameters close to the values
observed on fresh semen. Knowing that cryopreservation of boar semen is reduced
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compared to other species, this type of studies involving relaxin would be of great
importance for the swine industry, knowing that it will lead to maximize the use of fresh
sperm semen due to the time window widening while boar sperm can be manipulate.
Trying to understand how relaxin is improving motility, we conducted some
experiments to determine whether or not boar sperm possess relaxin receptors (RXFP1
and RXFP2) in their membrane. Both receptors were found there. Although, we did not
quantify the amount of these two receptors, we did notice that the presence of RXFP2
was higher than RXFP1, which is reported to be as the direct receptor for the ligand
relaxin. It suggests that quantification of these receptors and their specific location within
the sperm cells could be the next step, and if there is some possible implications of their
localization in the spermatozoa with regard to motility.
After having determined the presence of both relaxin receptors and following the
same line of thought stated previously on how relaxin might be acting, we wanted to go
deeper and evaluate the intracellular cAMP concentrations in sperm cells after treatment
with relaxin. We did not evidence any change in the intracellular cAMP content in sperm
cells during storage as the initial pathway postulated in this study by which relaxin might
be carrying out its effects on sperm motility. This study suggests that analysis of different
pathways at a molecular level is of great interest in seeking out for a better understanding
on how relaxin is acting.
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